Search

Your search keyword '"Schwanke C"' showing total 2 results
Start Over Author "Schwanke C" Journal journal of virus eradication
2 results on '"Schwanke C"'

1. Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to antiviral therapy

Author

Schwarz, M., primary, Schwarz, C., additional, Schütz, A., additional, Schwanke, C., additional, Krabb, E., additional, Schubert, R., additional, Liebich, S.-T., additional, Bauer, D., additional, Burghart, L., additional, Brinkmann, L., additional, Gutic, E., additional, Reiberger, T., additional, Haltmayer, H., additional, and Gschwantler, M., additional

Published
2023
Full Text
View/download PDF

2. Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy

Author

Schwarz, M., Schwarz, C., Schütz, A., Schwanke, C., Krabb, E., Schubert, R., Liebich, S.-T., Bauer, D., Burghart, L., Brinkmann, L., Gutic, E., Reiberger, T., Haltmayer, H., and Gschwantler, M.

Abstract

Despite effective direct-acting antivirals (DAAs), hepatitis C virus (HCV) prevalence is high among people who inject drugs (PWIDs) and non-adherence to therapy remains a major obstacle towards HCV elimination in this subpopulation. To overcome this issue, we have combined ongoing opioid agonist therapy (OAT) with DAAs in a directly-observed therapy (DOT) setting.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results